Atlanta, GA, United States of America

Keleigh Jo Strudthoff

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keleigh Jo Strudthoff: Innovator in Ocular Injection Technology

Introduction

Keleigh Jo Strudthoff is a notable inventor based in Atlanta, GA (US). She has made significant contributions to the field of ocular medicine through her innovative designs and solutions. Her work focuses on improving the delivery of medications through ocular injection.

Latest Patents

Keleigh holds a patent for an "Ocular injection kit, packaging, and methods of use." This apparatus includes a first tray member, a second tray member, and a lid. The first tray member has a first portion and a second portion, where the first portion defines a first volume, and the second portion is designed to receive a medicament container. The second tray member defines a third volume with a sidewall that includes a retention portion to securely hold an ocular injector. The design ensures that the ocular injector is enclosed and maintains sterility, which is crucial for medical applications.

Career Highlights

Keleigh is currently employed at Clearside Biomedical, Inc., where she continues to develop innovative solutions in ocular drug delivery. Her work has the potential to enhance patient outcomes and streamline the process of ocular injections.

Collaborations

Keleigh collaborates with talented professionals in her field, including Thomas Edward Godfrey and Rafael Victor Andino. These partnerships foster a creative environment that drives innovation and advances the technology in ocular medicine.

Conclusion

Keleigh Jo Strudthoff is a pioneering inventor whose work in ocular injection technology is making a significant impact in the medical field. Her dedication to innovation and collaboration continues to push the boundaries of what is possible in ocular drug delivery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…